The United States is facing an absolutely devastating opioid crisis.
As of September 2017, more than 2 million Americans are dependent on prescription pain pills like opiates, according to CNN.
The number of opioid-related deaths rose 75%, from roughly 20,000 in 2010 to 35,000 in 2015. That means opioid-based drugs kill more than 100 Americans every day.
Never miss a single....More>>>
&l;p&g;&l;img class=&q;size-large wp-image-17&q; src=&q;http://blogs-images.forbes.com/rcarson/files/2018/04/GettyImages-688949102-1200×701.jpg?width=960&q; alt=&q;&q; data-height=&q;701&q; data-width=&q;1200&q;&g; Ask yourself: Am I&a;nbsp;financially prepared for retirement?
Becoming a first-time grandfather makes one acutely aware of the number of years left on this planet. Suddenly,....More>>>
Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in....More>>>
How to play the turnaround in the Brazilian economy
Investing in emerging markets always has a heightened amount of risk associated with it. However, large and mid-cap stocks can help mitigate the heightened amount of risk. This is why I believe that the iShares MSCI Brazil Index (EWZ) is the safest way to play the turnaround in the Brazilian economy. The MSCI Brazil 25/50 Index is designed....More>>>
Related MRK Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim The Stocks That Moved The S&P, Dow And Nasdaq Today The Vetr community has upgraded $MRK to 3.5-Stars. (Vetr)
Related ONVO Add 3D Printing To Your Portfolio With These Stocks Organovo Holdings Sees FY 2016 Revs From Prior....More>>>
Gold backed off on Wednesday, as traders and investors opted for individual company equities. However, fundamental and technical data still suggests gold’s in for much higher levels ahead. With Trump’s ongoing reflationary theme, commodities in general have continued to trade higher, albeit not without some volatility along the way, but gold’s been one of the bigger benefactors....More>>>
An estimated 36.7 million people around the world have HIV. Around 17 million of them are taking prescription drugs to treat their condition.The total global HIV drug market totals more than $20 billion annually.
There are several choices for investing in HIV drug stocks. Three of the best options for long-term investors are Gilead Sciences (NASDAQ:GILD), GlaxoSmithKline (NYSE:GSK), and Merck....More>>>
One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four weeks.
Quiet periods for four recent IPOs are set to expire next week. Street research is expected on Monday for gene-edited crop....More>>>
The lull is over. The annual February pause in IPO activity lasted longer than normal, but 2018’s record-breaking start now looks ready to resume. This week IPOs began launching and another billion-dollar IPO joined the pipeline.
One IPO priced this week, the first in almost a month. AI-based biotech BioXcel Therapeutics priced at the low end and finished flat at the offer price. Three....More>>>
A flurry of IPOs joined the calendar to kick off the new year, most notably ADT. Less than two years since Apollo took the security services behemoth private, ADT (NYSE:ADT) launched a $2 billion public offering that will value the company at $14 billion.
After postponing its IPO in 2017, fracker Liberty Oilfield Services (Pending:BDFC) will be making a second attempt now that oil prices....More>>>